Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D Trial) in adults with cystic fibrosis

Alisa K. Sivapiromrat, Pichatorn Suppakitjanusant, Yanling Wang, Jose Binongo, William R. Hunt, Andrew Gewirtz, Jessica A. Alvarez, Chengcheng Hu, Samuel Weinstein, Ishaan Jathal, Thomas R. Ziegler, Vin Tangpricha
doi: https://doi.org/10.1101/2024.01.04.24300860

Article usage

Article usage: January 2024 to June 2025

AbstractFullPdf
Jan 20242121151
Feb 202487646
Mar 202487551
Apr 2024511126
May 202426510
Jun 20241417
Jul 2024211624
Aug 202420717
Sep 20242227
Oct 20241653
Nov 202428111
Dec 20243129
Jan 202517413
Feb 2025262911
Mar 2025283010
Apr 202529912
May 202532534
Jun 2025524
Back to top
Posted January 05, 2024.
Download PDF
Data/Code
Email
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D Trial) in adults with cystic fibrosis
Alisa K. Sivapiromrat, Pichatorn Suppakitjanusant, Yanling Wang, Jose Binongo, William R. Hunt, Andrew Gewirtz, Jessica A. Alvarez, Chengcheng Hu, Samuel Weinstein, Ishaan Jathal, Thomas R. Ziegler, Vin Tangpricha
medRxiv 2024.01.04.24300860; doi: https://doi.org/10.1101/2024.01.04.24300860
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area